OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IVA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Inventiva SA (IVA) Earnings Date & Reports

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IVA is expected to report earnings to fall 66.77% to -60 cents per share on September 29

Q2'25

Est.

$-0.60

Q4'24

Missed

by $1.39

Q3'24

Missed

by $0.20

Q2'24

Missed

by $0.17

Q1'24

Beat

by $0.04

The last earnings report on March 26 showed earnings per share of -182 cents, missing the estimate of -43 cents. With 3.43K shares outstanding, the current market capitalization sits at 470.83M.

View a ticker or compare two or three

Compare

IVA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IVA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IVA showed earnings on March 26, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

50 rue de Dijon

Phone

+33 380447500

Employees

123

Web

https://www.inventivapharma.com